OKYO Pharma Ltd
Ownership
Ownership Structure
Who owns OKYO Pharma Ltd (OKYO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 53.2% of the shares are freely tradable; institutional investors hold 20.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Woodline Partners LP | 6.96 | 3,652,190 | +0.0 | 03/31/2026 |
| MAVEN SECURITIES Ltd | 2.24 | 1,175,535 | +0.0 | 03/31/2026 |
| Stonepine Capital Management Llc | 1.62 | 850,000 | +0.0 | 03/31/2026 |
| Balyasny Asset Management LLC | 1.11 | 584,796 | +0.0 | 03/31/2026 |
| Opaleye Management Inc | 0.72 | 375,204 | +0.0 | 06/30/2026 |
| UBS Group AG | 0.11 | 59,760 | +2,651.4 | 03/31/2026 |
| XTX Topco Ltd | 0.07 | 37,652 | +113.8 | 03/31/2026 |
| RSM US WEALTH MANAGEMENT LLC | 0.06 | 33,255 | +0.0 | 06/30/2026 |
| HPM Partners LLC | 0.02 | 12,812 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.02 | 12,090 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.